Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Carcinoma, Hepatocellular × DNA × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2 Vulvar Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Teratoma, Ovarian 1 Struma Ovarii 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Ovarian Neoplasms 1 Metabolic Syndrome 1 Lung Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1 Head and Neck Neoplasms 1 Genetic Predisposition to Disease 1 Disease 1 Diabetes Mellitus 1 Cardiovascular Diseases 1 Carcinoma, Hepatocellular 1

Interventions

Sorafenib 16 lenvatinib 15 Hepatectomy 15 Blood Specimen Collection 10 Immune Checkpoint Inhibitors 9 Liver Transplantation 7 atezolizumab 6 Surgical Procedures, Operative 6 gadolinium ethoxybenzyl DTPA 5 Radiofrequency Ablation 5 Observation 5 Bevacizumab 5 regorafenib 4 Radiotherapy 4 Magnetic Resonance Spectroscopy 4 tislelizumab 3 sintilimab 3 donafenib 3 camrelizumab 3 Polymerase Chain Reaction 3 Neoadjuvant Therapy 3 Mass Spectrometry 3 Immunohistochemistry 3 Angiogenesis Inhibitors 3 toripalimab 2 spartalizumab 2 pembrolizumab 2 entecavir 2 adefovir dipivoxil 2 Tenofovir 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05390112 2022-05-25

Mona-Lisa

University Hospital, Rouen

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡